🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07672210
Recruiting Observational

PregnAncy-Related Aortic DISsEction in China

NCT07672210 · tracked via the Priya Life Science China tracker
Sponsor
DeltaHealth Hospital · Shanghai
Phase
Observational
Started
2026-03-17
Last updated
2026-07-17

Condition(s) studied

Pregnancy ComplicationAortic DissectionMarfan SyndromeLoeys-Dietz SyndromeVascular Ehlers-Danlos SyndromeMaternal and Neonatal Outcomes

Investigational drug(s) / intervention(s)

Intervention strategies including medication or surgery

Intervention strategies including medication or surgery: Medication or surgery (delivery or surgery first, or single-stage delivery and surgery) is determined based on gestational age and the type of AD, and also in consideration of the decisions made by the patient and their relatives.

Study summary

A multicenter observational study on pregnancy-related aortic dissection

Eligibility

Sex
FEMALE
Min age
16 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Aortic dissection is diagnosed based on symptoms and physical findings, and confirmed by computed tomographic angiography (CTA) and/or transthoracic echocardiography * Aortic dissection occurring during pregnancy or within 12 weeks postpartum Exclusion Criteria: * Previous history of aortic dissection, but no new aortic dissection occurring during pregnancy or within 12 weeks postpartum

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
DeltaHealth Hospital Shanghai Shanghai Shanghai Municipality Recruiting
Beijing Anzhen Hospital Beijing China Recruiting
Guangdong Provincial Hospital Guangzhou China Recruiting
Wuhan Union Hospital Wuhan China Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07672210 on ClinicalTrials.gov ↗ ← All trials in China